Trialect

Active

Advanced Visiting Fellowship in Hepatology and Digestive Oncology

Hôpital BEAUJON

Hôpital BEAUJON, 100 Boulevard du Général Leclerc, 92110 Clichy, FRANCE

Dr. Mohamed Bouattour is a medical specialist at Beaujon University Hospital in Clichy, France. He has been a practitioner since 2007, with board certifications in Gastroenterology, Hepatology, and Medical Oncology. His primary expertise lies in the management and research of liver tumors, including hepatocellular carcinoma (HCC) and cholangiocarcinoma. He has served as the principal investigator for several phase 1 to 3 clinical trials focusing on these conditions.

Dr. Bouattour is actively involved in both national and international scientific collaborations and has authored numerous publications in the fields of liver and cancer diseases. He is a member of prominent societies such as the European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Diseases (AASLD), the International Liver Cancer Association (ILCA), and the American Society of Clinical Oncology (ASCO)

Main Areas of Interest

This fellowship will focus on the following core areas within hepatology and oncology:

Primary Liver Tumors:

Focus on hepatocellular carcinoma (HCC) and cholangiocarcinoma.
Advanced diagnosis and management strategies for liver cancers.

Clinical Trial Design and Management:

Development and execution of Phase 1 to Phase 3 clinical trials in liver oncology.
Understanding protocols for clinical research involving liver tumors.

Multidisciplinary Care in Digestive Oncology:

Collaborative care models involving hepatologists, oncologists, radiologists, and surgeons.
Integrating medical, interventional, and surgical approaches.

Innovative Liver Cancer Treatments:

Exploring novel therapies, including targeted therapy, immunotherapy, and precision medicine for liver cancer.
Reviewing current and emerging clinical guidelines.

Specialties

Hepatology

Gastroenterology

Oncology

General Medicine

Techniques You Will Learn

Participants will gain limited hands-on experience in the following techniques (this is not a board certified fellowship; this is a visiting program to gain experience only):

Advanced Diagnostic Techniques for Liver Cancer:

Imaging modalities: MRI, CT, and PET scans specific to liver tumors.
Biomarker identification and interpretation for HCC and cholangiocarcinoma.

Interventional Oncology Procedures:

Techniques include transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and radioembolization.

Clinical Trial Protocol Development:

Crafting study designs, implementing protocols, and managing patient cohorts in Phase 1-3 trials.
Best practices in ethical considerations and regulatory compliance for liver cancer trials.

Multidisciplinary Tumor Board Participation:

Collaborative decision-making processes in complex hepatobiliary cancer cases.
Reviewing case studies and presenting research data.

Curriculum

This is a sample curriculum and it can be customized

Week 1-2:
Introduction and Overview

Orientation and review of institutional protocols.
Understanding the epidemiology and clinical presentation of primary liver tumors.
Basics of imaging and liver function tests for tumor diagnosis.

Week 3-4:
Diagnosis and Staging

Limited Hands-on sessions with imaging and pathology teams to learn staging techniques.
Detailed study of biomarkers and diagnostic criteria.
Participation in patient case reviews with the hepatology team.

Week 5-6:
Therapeutic Approaches

Review of therapeutic modalities, including local and systemic treatments.
Observing and assisting in interventional procedures (TACE, RFA, etc.).
Learning about targeted therapy and immunotherapy options in advanced liver cancer.

Week 7-8:
Clinical Trials and Research

Immersive experience in ongoing clinical trials: protocol adherence, patient enrollment, and data management.
Developing skills in writing clinical trial protocols.
Reviewing ethical and regulatory requirements for trials in hepatology.

Week 9-10:
Multidisciplinary Management

Active participation in tumor boards and interdisciplinary meetings.
Integrating medical, interventional, and surgical management plans for complex cases.
Case study presentations by fellows.

Week 11-12:
Capstone and Future Directions

Final presentation by fellows on a selected research topic or case study.
Feedback sessions with Dr. Bouattour and senior consultants.
Exploring future research opportunities and collaborations.

Accommodation

Try airbnb.com

Fees and Program Logistics

This program has the following durations available:

Duration	Fee
2 weeks	$1,000.00
4 weeks	$1,500.00
8 weeks	$2,750.00
12 weeks	$3,750.00

This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.

Who Can Apply

Hepatologists, Gastroenterologists, Digestive Oncologist, Liver Pathologist; liver surgeon,s and Radiologists involved in the management in liver diseases and liver cell cancers can participate

Host Details

Host Name: Dr Mohamed BOUATTOUR

Affiliation: Hôpital BEAUJON

Address: 100 Boulevard du Général Leclerc 92110 Clichy, FRANCE

Website URL: https://lefoie.org/

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.